About this Journal Submit a Manuscript Table of Contents
Case Reports in Hematology
Volume 2012 (2012), Article ID 197347, 3 pages
http://dx.doi.org/10.1155/2012/197347
Case Report

Primary Mediastinal Large B-Cell Lymphoma during Pregnancy

1Division of Hematology/Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, 1475 NW 12th Avenue, Miami, FL 33136, USA
2Department of Anesthesiology, Perioperative Medicine and Pain Management, University of Miami Miller School of Medicine, 1475 NW 12th Avenue, Miami, FL 33136, USA
3Department of Pathology, University of Miami Miller School of Medicine, 1475 NW 12th Avenue, Miami, FL 33136, USA

Received 12 August 2012; Accepted 13 September 2012

Academic Editors: T. Sonoki, S. Storti, and P. Tsirigotis

Copyright © 2012 Cesar A. Perez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. J. Hurley, J. V. McKinnell, and M. S. Irani, “Hematologic malignancies in pregnancy,” Obstetrics and Gynecology Clinics of North America, vol. 32, no. 4, pp. 595–614, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Pentheroudakis and N. Pavlidis, “Cancer and pregnancy: poena magna, not anymore,” European Journal of Cancer, vol. 42, no. 2, pp. 126–140, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. J. S. Lee, P. M. Bracci, and E. A. Holly, “Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone use,” American Journal of Epidemiology, vol. 168, no. 3, pp. 278–288, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. A. M. Evens, R. Advani, I. S. Lossos, et al., “Lymphoma in pregnancy: excellent fetal outcomes and maternal survival in a large multicenter analysis,” Blood, vol. 118, Abstract 94, 2011.
  5. T. P. Vassilakopoulos, G. A. Pangalis, A. Katsigiannis, et al., “Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care,” Oncologist, vol. 17, pp. 239–249, 2012.
  6. N. L. Harris, E. S. Jaffe, H. Stein et al., “A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group,” Blood, vol. 84, no. 5, pp. 1361–1392, 1994. View at Scopus
  7. P. M. Banks and R. A. Warnke, “Mediastinal (thymic) large B-cell lymphoma,” in World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues, E. S. Jaffe, N. L. Harris, and H. Stein, Eds., pp. 175–176, IARC Press, Lyon, France, 2001.
  8. P. W. Johnson and A. J. Davies, “Primary mediastinal B-cell lymphoma,” Hematology, pp. 349–358, 2008. View at Scopus
  9. A. Rosenwald, G. Wright, K. Leroy et al., “Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma,” Journal of Experimental Medicine, vol. 198, no. 6, pp. 851–862, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. V. De Sanctis, E. Finolezzi, M. F. Osti et al., “MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma,” International Journal of Radiation Oncology Biology Physics, vol. 72, no. 4, pp. 1154–1160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. H. A. Azim Jr., N. Pavlidis, and F. A. Peccatori, “Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: hematological tumors,” Cancer Treatment Reviews, vol. 36, no. 2, pp. 110–121, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Dunleavy, S. Pittaluga, J. Janik, et al., “Primary mediastinal large B-cell lymphoma outcome may be significantly improved by the addition of rituximab to dose-adjusted (DA)-EPOCH and obviates the need for radiation: results from a prospective study for 44 patients,” Blood, vol. 108, Abstract 209, 2006.
  13. A. Avilés and N. Neri, “Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero,” Clinical Lymphoma, vol. 2, no. 3, pp. 173–177, 2001. View at Scopus